Latest filing published 14 Aug 2026 for Rhythm Pharmaceuticals, INC., €737k.
Jennifer Kayden Lee appears in our data through filings on Rhythm Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 56 filings cover trades dated from 7 August 2023 to 13 August 2026.
On the market, this insider has only sold: 33 sales, €15.1M in total. Outside the open market, there are 2 share grants and 21 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 14 August 2026: an option exercise of €737k, in Rhythm Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations